Dr Prakash A Mody re-appointed as Chairman, MD of Unichem Labs

Published On 2023-06-28 08:00 GMT   |   Update On 2023-06-28 08:01 GMT

Mumbai: Unichem Laboratories has announced the re-appointment of Dr Prakash A. Mody as the Chairman & Managing Director of the Company for a period of three years commencing from July 1, 2023."We inform you that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors at its Meeting held Monday, June 26, 2023, approved the re-appointment of Dr. Prakash...

Login or Register to read the full article

Mumbai: Unichem Laboratories has announced the re-appointment of Dr Prakash A. Mody as the Chairman & Managing Director of the Company for a period of three years commencing from July 1, 2023.

"We inform you that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors at its Meeting held Monday, June 26, 2023, approved the re-appointment of Dr. Prakash A. Mody (DIN:00001285) as the Chairman & Managing Director of the Company for a period of three years commencing from July 1, 2023, subject to the approval of the Shareholders," the company stated in a BSE filing.

Dr. Prakash A. Mody, is the son of founder promoter, Late Shri Amrut Mody. He completed his post-graduation from the University of Mumbai followed by a Ph.D. in organic chemistry. He is a graduate alumnus of Harvard Business School and the former president of the Indian Pharmaceutical Alliance, the industry body representing research-based national pharmaceutical companies. He was appointed as the Director of the Company in the year 1974.

Dr. Mody has a rich and varied experience in the industry to which the Company belongs and has been at the helm of the affairs of the Company for over forty years and during this period the Company has achieved growth and has spread its footprints in the international markets to more than eighty countries in US, Europe, Ireland, South Africa, Brazil, etc. He is a member of the Stakeholders Relationship Committee and Chairman of the Corporate Social Responsibility Committee and Risk Management Committee of the Board of Directors of the Company. Dr. Mody is also an Independent Director of Kewal Kiran Clothing Limited and is a member of its Nomination and Remuneration Committee.

Read also: Unichem Labs bags USFDA nod for chronic angina drug Ranolazine Extended Release



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News